Stock ATXI AVENUE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Avenue Therapeutics, Inc.

Equities

ATXI

US05360L4032

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
3.62 USD 0.00% Intraday chart for Avenue Therapeutics, Inc. -2.95% -70.02%
May. 16 Avenue Therapeutics, Inc Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) CI
May. 15 Avenue Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. ATXI Stock
  4. Revisions Avenue Therapeutics, Inc.